NASDAQUtilitiesIndependent Power ProducersSnapshot 2026-08-31
Reading CEG? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Warn: Primary pillar under pressure — Operating income from Calpine integration reaches $2.33B in Q1 2026: metric not reported.
Constellation Energy is growing earnings with EPS guidance of $11.00 to $12.00 for 2026. The company is integrating Calpine well, raising operating income from $451M to $2.33B in one year. It is expanding renewable energy projects with long-term nuclear deals. These support steady revenue growth and durable profits.
The recent sharp selloff and guidance cut show risks to earnings growth. The sector faces headwinds and the company’s profit margins could weaken. If integration or renewable expansion slows, growth may stall.
The price is about 1% above our fair value near $244, reflecting roughly 13% revenue growth expected by analysts. Our fair value is 32% below the Street median, indicating more cautious estimates than consensus.
Breaks if: Operating income from integration falls below $2.33B in Q1 2026
Complete the integration of Calpine Corporation to expand generation portfolio and commercial platform.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a mix of growth and integration challenges. CEG is in a transitional phase following its acquisition of Calpine, focusing on expanding its renewable energy projects while navigating sector headwinds.
The current valuation suggests that the market has priced in a level of fragility due to weak execution quality, but it remains justified given the recent performance. CEG trades at a premium compared to its peers, indicating that investors expect continued progress despite recent challenges.
Fundamentals are likely to show mixed results as management integrates the Calpine acquisition and affirms its earnings guidance. However, there is a near-term risk of missing expectations, especially as industry peers have faced challenges recently.
The thesis hinges on CEG's ability to maintain or improve its earnings guidance and successfully integrate Calpine. Additionally, the performance of sector bellwethers and their impact on market sentiment will be crucial for CEG's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports the thesis. The company affirmed its 2026 EPS guidance of $11.00 - $12.00 per share. This positive news enhances confidence in its financial outlook.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 4 of last 4 quarters. The acquisition of Calpine was completed on January 7, 2026 for approximately $22 billion, expanding Constellation's generation portfolio to about 28 GW. Management has consistently emphasized integration and value capture from Calpine, and the financials show increased revenues and operating income post-acquisition, indicating delivering progress on this priority.
“We remain focused on integrating Calpine, capturing the value of our expanded fleet and investing in opportunities.”
“Our first-quarter results reflect continued operational excellence from our entire organization, integrating two great companies.”
“Completed acquisition of Calpine Corporation, expanding our generation portfolio and commercial platform.”
“Calpine acquisition integration remains a key focus for growth and operational excellence.”
Breaks if: EPS falls below $11.0 in FY26
Breaks if: Renewable energy project expansion stalls or reverses in next 4 quarters
Over the next 1 to 3 years, CEG's performance will depend on its execution of strategic priorities and the broader utilities sector's health. Not investment advice.
